Publications by authors named "Tamara Perez-Jeldres"

To understand the role of T cells in the pathogenesis of ulcerative colitis (UC), we analyzed colonic T cells isolated from patients with UC and controls. Here we identified colonic CD4 and CD8 T lymphocyte subsets with gene expression profiles resembling stem-like progenitors, previously reported in several mouse models of autoimmune disease. Stem-like T cells were increased in inflamed areas compared to non-inflamed regions from the same patients.

View Article and Find Full Text PDF

Background And Aims: Latin American populations remain underrepresented in genetic studies of inflammatory bowel diseases (IBDs). Most genetic association studies of IBD rely on Caucasian, African, and Asian individuals. These associations have yet to be evaluated in detail in the Andean region of South America.

View Article and Find Full Text PDF

Lactose intolerance (LI) and vitamin D deficiency (VDD) have been linked to inflammatory bowel disease (IBD). We conducted an observational study in 192 Chilean IBD patients to investigate the prevalence of a specific gene variant (LCT-13910 CC genotype) associated with LI and the prevalence of VDD/Vitamin D Receptor (VDR) gene variants. Blood samples were analyzed using Illumina's Infinium Global Screening Array.

View Article and Find Full Text PDF

Background: Experimental reports have demonstrated that florfenicol (FFC) exerts potent anti-inflammatory effects, improving survival in a murine endotoxemia model. Considering the anti-inflammatory and immunomodulatory properties of pentoxifylline (PTX) as an adjuvant to enhance the efficacy of antibiotics, the anti-inflammatory effects of the interaction FFC/PTX over the Lipopolysaccharide (LPS)-induced acute inflammatory response was evaluated in rabbits.

Methods: Twenty-five clinically healthy New Zealand rabbits (3.

View Article and Find Full Text PDF

Colitis is characterized by an exacerbated intestinal immune response, but the genetic and other mechanisms regulating immune activation remain incompletely understood. In order to identify new pathways leading to colitis, we sought to identify genes with increased expression in the colons of patients that also are near loci identified by genome wide association studies (GWAS) associated with IBD risk. One such SNP, rs9557195 was of particular interest because it is within an intron of , known to be important for lymphocyte migration.

View Article and Find Full Text PDF

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn disease (CD), has emerged as a global disease with an increasing incidence in developing and newly industrialized regions such as South America. This global rise offers the opportunity to explore the differences and similarities in disease presentation and outcomes across different genetic backgrounds and geographic locations. Our study includes 265 IBD patients.

View Article and Find Full Text PDF
Article Synopsis
  • Sphingosine-1-phosphate (S1P) is a lipid metabolite that interacts with 5 G-protein-coupled receptors to regulate lymphocyte trafficking, impacting immune responses and diseases.
  • An S1P gradient (low in tissues, high in blood) is crucial for lymphocyte movement; modulating this pathway can therapeutically affect conditions like multiple sclerosis and other immune-mediated diseases.
  • While some S1PR modulators show promise in treating autoimmune diseases and COVID-19, they come with potential side effects such as leukopenia and elevated transaminases, requiring careful administration.
View Article and Find Full Text PDF

Inflammatory bowel disease is characterized by an exacerbated intestinal immune response, but the critical mechanisms regulating immune activation remain incompletely understood. We previously reported that the TNF-superfamily molecule TNFSF14 (LIGHT) is required for preventing severe disease in mouse models of colitis. In addition, deletion of lymphotoxin beta receptor (LTβR), which binds LIGHT, also led to aggravated colitis pathogenesis.

View Article and Find Full Text PDF

Background And Aims: Intestinal biopsy sampling during IBD trials represents a valuable adjunct strategy for understanding drug responses at the tissue level. Given the length and distinctive embryonic origins of the proximal and distal colon, we investigated whether inherent regional differences of immune cell composition could introduce confounders when sampling different disease stages, or pre/post drug administration. Here, we capitalise on novel mass cytometry technology to perform deep immunophenotyping of distinct healthy colonic segments, using the limited numbers of biopsies that can be harvested from patients.

View Article and Find Full Text PDF
Article Synopsis
  • - The study explores the role of sphingosine-1-phosphate lyase (SPL) in the intestine, particularly its impact on S1P levels and lymphocyte behavior in both healthy and inflamed conditions like inflammatory bowel disease (IBD).
  • - Researchers conducted experiments using specific SPL inhibitors on mice with Crohn's-like chronic ileitis to observe changes in lymphocyte circulation, inflammation levels, and tissue S1P concentrations.
  • - Results showed that SPL is widely expressed in the gut, primarily in intestinal epithelial cells, and its inhibition significantly raised local S1P levels, suggesting a potential therapeutic avenue for managing gut inflammation without common side effects linked to S1P receptor targeting.
View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory Bowel Diseases (IBDs) are chronic conditions affecting the gastrointestinal tract, with treatments like biological therapies showing varied effectiveness due to their complexity and immunogenicity.
  • Recent advancements in understanding IBD mechanisms have led to new treatment options, particularly focusing on small molecules (SMs) which are easier to administer and less likely to provoke immune responses.
  • Janus Kinase (JAK) inhibitors and Sphingosine-1-Phosphate Receptor (S1PR) agonists are emerging as promising SM treatments for IBD, targeting specific pathways that contribute to the disease's pathology.
View Article and Find Full Text PDF
Article Synopsis
  • After 20 years of focusing on pro-inflammatory cytokines for IBD treatment, new strategies targeting leukocyte traffic have emerged as effective alternatives.
  • Two drugs, natalizumab and vedolizumab, are already approved, with more in phase 3 trials targeting various molecules involved in immune cell movement.
  • Future treatments may include new small molecules, allosteric inhibitors, and nanovectors that enhance the modulation of inflammatory cell trafficking in IBD.
View Article and Find Full Text PDF

Background: Novel therapeutics for inflammatory bowel disease (IBD) are under development, yet mechanistic readouts at the tissue level are lacking. Techniques to assess intestinal immune composition could represent a valuable tool for mechanism of action (MOA) studies of novel drugs. Mass cytometry enables analysis of intestinal inflammatory cell infiltrate and corresponding molecular fingerprints with unprecedented resolution.

View Article and Find Full Text PDF

Purpose: To derive the best magnetic resonance enterography (MRE) approach for detecting activity and severe lesions in Crohn's disease (CD) to use for selecting patients and measuring response to treatment in clinical trials.

Methods: We compared the accuracies of MRE (T2-weighted sequences, DWI (b = 800 s/mm) sequences, combined T2-weighted and DWI sequences, combined T2-weighted or DWI sequences, and MaRIA score based on T2-weighted and contrast-enhanced T1-weighted sequences) versus ileocolonoscopy (SES-CD) performed within 1 month. Bowel segments were classified as inactive (SES-CD < 2), active (SES-CD ≥ 2), or active with severe lesions (ulcers seen at endoscopy).

View Article and Find Full Text PDF

Background: Magnetic resonance enterography (MRE) is an accurate examination for assessing activity in Crohn's disease (CD). Various MRE indices have been developed for that purpose, but have not been directly compared. The aim of the study was to compare the diagnostic accuracy of three MRE indices for detecting and grading disease activity in CD, using endoscopy as gold standard.

View Article and Find Full Text PDF

Background: Psoriasis induced by anti-tumor necrosis factor-α (TNF) therapy has been described as a paradoxical side effect.

Aim: To determine the incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in a large nationwide cohort of inflammatory bowel disease patients.

Methods: Patients with inflammatory bowel disease were identified from the Spanish prospectively maintained Estudio Nacional en Enfermedad Inflamatoria Intestinal sobre Determinantes genéticos y Ambientales registry of Grupo Español de Trabajo en Enfermedad de Croh y Colitis Ulcerosa.

View Article and Find Full Text PDF